Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Adibzadeh

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Cancer Immunology, Immunotherapy : CII|August 4, 1999
Prerequisites for the immunotherapy of cancerG Pawelec, A Engel, M Adibzadeh
Methods in Molecular Medicine|February 22, 2012
Identification of differentially expressed genes in young and senescent T cellsA Engel, M Adibzadeh, G Pawelec
Experimental Gerontology|August 5, 1999
T cell immunosenescence in vitro and in vivoG Pawelec, W Wagner, M Adibzadeh, et al.
Mechanisms of Ageing and Development|February 1, 1997
The T cell in the ageing individualG Pawelec, M Adibzadeh, R Solana, et al.
Mechanisms of Ageing and Development|September 15, 1995
Long-term culture of monoclonal human T lymphocytes: models for immunosenescence?M Adibzadeh, H Pohla, A Rehbein, et al.
Cytokine|December 1, 1996
Interleukin 10 protects activated human T lymphocytes against growth factor withdrawal-induced cell death but only anti-fas antibody can prevent activation-induced cell deathG Pawelec, A Hambrecht, A Rehbein, et al.
Current Protocols in Immunology|April 25, 2008
Measurement of polyclonal and antigen-specific cytotoxic T cell functionW E Biddison, R Lichtenfels, M Adibzadeh, et al.
Immunological Reviews|February 26, 1998
Human T-cell clones in long-term culture as a model of immunosenescenceG Pawelec, A Rehbein, K Haehnel, et al.
Experimental Gerontology|November 1, 1996
Decreased proliferative capacity and increased susceptibility to activation-induced cell death in late-passage human CD4+ TCR2+ cultured T cell clonesG Pawelec, D Sansom, A Rehbein, et al.
Vaccine|February 26, 2000
In vitro senescence models for human T lymphocytesG Pawelec, M Adibzadeh, A Rehbein, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Cancer Immunology, Immunotherapy : CII|August 4, 1999
Prerequisites for the immunotherapy of cancerG Pawelec, A Engel, M Adibzadeh
Methods in Molecular Medicine|February 22, 2012
Identification of differentially expressed genes in young and senescent T cellsA Engel, M Adibzadeh, G Pawelec
Experimental Gerontology|August 5, 1999
T cell immunosenescence in vitro and in vivoG Pawelec, W Wagner, M Adibzadeh, et al.
Mechanisms of Ageing and Development|February 1, 1997
The T cell in the ageing individualG Pawelec, M Adibzadeh, R Solana, et al.
Mechanisms of Ageing and Development|September 15, 1995
Long-term culture of monoclonal human T lymphocytes: models for immunosenescence?M Adibzadeh, H Pohla, A Rehbein, et al.
Cytokine|December 1, 1996
Interleukin 10 protects activated human T lymphocytes against growth factor withdrawal-induced cell death but only anti-fas antibody can prevent activation-induced cell deathG Pawelec, A Hambrecht, A Rehbein, et al.
Current Protocols in Immunology|April 25, 2008
Measurement of polyclonal and antigen-specific cytotoxic T cell functionW E Biddison, R Lichtenfels, M Adibzadeh, et al.
Immunological Reviews|February 26, 1998
Human T-cell clones in long-term culture as a model of immunosenescenceG Pawelec, A Rehbein, K Haehnel, et al.
Experimental Gerontology|November 1, 1996
Decreased proliferative capacity and increased susceptibility to activation-induced cell death in late-passage human CD4+ TCR2+ cultured T cell clonesG Pawelec, D Sansom, A Rehbein, et al.
Vaccine|February 26, 2000
In vitro senescence models for human T lymphocytesG Pawelec, M Adibzadeh, A Rehbein, et al.
Pageof 2